We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current IMAB market cap is 67.89M. The company's latest EPS is CNY and P/E is N/A.
| Quarter End | Dec 2019 | Sep 2020 | Dec 2020 | Sep 2024 | |
|---|---|---|---|---|---|
| CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | |
| Total Revenue | 0 | 0 | 1.54B | 0 | |
| Operating Income | -333.86M | -395.56M | 1.06B | -12.95M | |
| Net Income | -381.62M | 12.22M | 1.04B | -20.51M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | |
| Total Revenue | 30M | 1.54B | 88.03M | -221.56M | 27.64M |
| Operating Income | -1.46B | 46.98M | -2.44B | -2.41B | -1.48B |
| Net Income | -1.49B | 470.92M | -2.33B | -2.51B | -1.47B |
| Quarter End | Dec 2019 | Sep 2020 | Dec 2020 | Sep 2024 | |
|---|---|---|---|---|---|
| CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | |
| Total Assets | 1.74B | 4.3B | 6.33B | 232.68M | |
| Total Liabilities | 668.09M | 556.44M | 706.65M | 14.8M | |
| Total Equity | -2.03B | 3.74B | 5.63B | 217.88M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | |
| Total Assets | 1.74B | 6.33B | 5.6B | 4.07B | 2.61B |
| Total Liabilities | 668.09M | 706.65M | 1.04B | 1.16B | 894.81M |
| Total Equity | -2.03B | 5.63B | 4.56B | 2.91B | 1.72B |
| Quarter End | Dec 2019 | Sep 2020 | Dec 2020 | Sep 2024 | |
|---|---|---|---|---|---|
| CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | |
| Operating | -867.98M | -582.63M | 433.56M | N/A | |
| Investing | 212.46M | -256.38M | -201.9M | N/A | |
| Financing | 152.71M | 2.6B | 3.44B | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | CNY (å…ƒ) | |
| Operating | -867.98M | 433.56M | -973.09M | -1.1B | -1.3B |
| Investing | 212.46M | -201.9M | -721.21M | 458.38M | 108.52M |
| Financing | 152.71M | 3.44B | 593.92M | 42.36M | 7.57M |
| Market Cap | 67.89M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 80.7M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.05 (5.67%) |
| Company Name | I MAB |
| Address |
po box 31119 grand cayman KY1 1205 |
| Website | https://www.i-mabbiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
